The New HHS: Tom Price and Value-Based Healthcare

RopesTalk
20/12/2016 7 min
The New HHS: Tom Price and Value-Based Healthcare

Listen "The New HHS: Tom Price and Value-Based Healthcare"

Descargar episodio Ver en sitio original

Episode Synopsis


What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.

More episodes of the podcast RopesTalk

AI at Work – Smarter, Not Riskier: Employer Strategies for Responsible AI Use 03/12/2025
Decoding SFDR 2.0: Navigating the European Commission’s Proposed ESG Reforms 26/11/2025
Culture & Compliance Chronicles: Inside the Wirecard Scandal—Whistleblowing, Retaliation & Reform with Pav Gill 12/11/2025
Practical Considerations for Retirement Plan Sponsors Evaluating Alternative Assets in 401(k)s 30/10/2025
Non-Financial Misconduct Miniseries: Episode 1 - Navigating the FCA's Regulatory Framework 28/10/2025
Fully Invested: Key Features and Developments in ‘34 Act Funds 27/10/2025
Culture & Compliance Chronicles: Boardroom Agility—Strategies for Modern Boards Managing Crises, Compliance & Collective Responsibility 15/10/2025
Navigating Health Plan M&A: Strategies for Success in the Medicare Advantage Market 15/10/2025
Fully Invested: The Rise of CITs – Why They’re a Compelling Path for Asset Managers Entering the 401(k) Plan and Retail Markets 14/10/2025
Non-binding Guidance: The Administration’s Focus on Direct-to-Consumer Prescription Drug Advertising 06/10/2025
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA